The global hospital-acquired infection control market will reach USD 34,909.7 million by 2030 developing at a CAGR of 1.6% during the projection period. This growth can be credited to the growing count of surgical conducts, rising knowledge regarding ecological and personal hygiene, and subsequent development in the occurrence of chronic illnesses.
In the past few years, an extreme surge in occurrences of cardiovascular diseases, neurological syndromes, and traumatic injuries, and the arrival of progressive medical technologies have been experienced. Because of such recurrent events, the industry for hospital-acquired infection control items is surging. For example, annually, the count of individuals going through neurological diseases or accidents is nearly 20 million and approximately 14 million of them need surgery.
The demand for hospital-acquired infection control items in ambulant surgical care centers is projected to advance at the highest CAGR, of 2%, during the forecast period, in the industry.
In recent years, the North American region dominated with the largest share, of 35%, in the hospital-acquired infection control market. This is credited to the rise in the elderly populace, the surge in the occurrence of chronic illnesses and hospital-acquired infections, and the existence of key industry players in the continent.
For example, in the U.S., the count of populaces aged more than 65 years is approximately 45 million and it is projected to reach more than 80 million by 2050. Furthermore, the occurrence of hospital-acquired infections in North America is very prominent. For instance, in American hospitals, the occurrence of HAIs is more than 1.5 million, and annually, 0.1 million demise happens because of this.
Hence, the growing count of surgical conducts, rising knowledge regarding ecological and personal hygiene, and subsequent development in the occurrence of chronic illnesses are the major factors propelling the industry.